Vera Therapeutics, Inc. - 10-Q Filing

Vera Therapeutics reports Q3 2025 financial results including details on the 2025 Loan Agreement and Ares Trading SA milestones.

SEC EDGAR ·

Tickers: $VERA

Read the full article at SEC EDGAR

More Regulatory news